Ashleigh A. McGirr, Kevin L. Schwartz, Upton Allen, Melinda Solomon, & Beate Sander. (2017). The cost-effectiveness of palivizumab in infants with cystic fibrosis in the Canadian setting: A decision analysis model. Taylor & Francis Group.
Chicago Style (17th ed.) CitationAshleigh A. McGirr, Kevin L. Schwartz, Upton Allen, Melinda Solomon, and Beate Sander. The Cost-effectiveness of Palivizumab in Infants with Cystic Fibrosis in the Canadian Setting: A Decision Analysis Model. Taylor & Francis Group, 2017.
MLA (9th ed.) CitationAshleigh A. McGirr, et al. The Cost-effectiveness of Palivizumab in Infants with Cystic Fibrosis in the Canadian Setting: A Decision Analysis Model. Taylor & Francis Group, 2017.
Warning: These citations may not always be 100% accurate.